Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

Five years on from the start of the pandemic, with its worldwide lockdowns and border closures, new data has revealed a way ...

Learn more about whether Halozyme Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's ...

Leukocyte count is an independent predictor of future postacute sequelae of severe acute respiratory coronavirus 2 infection (PASC) in postmenopausal women.

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Researchers found that COVID-19 may accelerate biological processes linked to Alzheimer’s, showing changes in brain-related ...

By Arnaud Fontanet - Physician, Director of the Epidemiology of Emerging Diseases Unit at the Institut Pasteur, Professor of ...

It's an unusual winter for respiratory illnesses. The flu is peaking twice: once in early January and again in February.

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...